A Prospective Randomized Trial to Assess the Cost Impact of Pharmacist-Initiated Interventions
McMullin, S. Troy
Hennenfent, Joel A.
Ritchie, David J.
Huey, Way Y.
Lonergan, Thomas P.
Schaiff, Robyn A.
Tonn, Michael E.
Bailey, Thomas C.
Archives of Internal Medicine 1999 October 25; 159(19): 2306- 2309
Showing items related by title, author, creator and subject.
Impact of a Family Information Leaflet on Effectiveness of Information Provided to Family Members of Intensive Care Unit Patients -- a Multicenter, Prospective, Randomized, Controlled Trial Azoulay, Elie; Pochard, Frédéric; Chevret, Sylvie; Jourdain, Merce; Bornstain, Caroline; Wernet, Anne; Cattaneo, Isabelle; Annane, Djilali; Brun, Frédéric; Bollaert, Pierre-Edouard; Zahar, Jean-Ralph; Goldgran- Toledano, Dany; Adrie, Christoph, Joly, Luc-Marie; Tayoro, Jerome; Desmettre, Thibaut; Pigne, Etienne; Parrot, Antoine; Sanchez, Olivier; Poisson, Catherine; Le Gall, Jean-Roger; Schlemmer, Benoît; Lemaire, François (2002-02-15)
Impact of Detailed Informed Consent on Research Subjects' Participation: A Prospective, Randomized Trial Marco, Catherine A. (2008-04)
Sex Bias and Underutilization of Lipid-Lowering Therapy in Patients With Coronary Artery Disease at Academic Medical Centers in the United States and Canada [For the Prospective Randomized Evaluation of the Vascular Effects of Norvase Trial (PREVENT) Investigators] Miller, Michael; Byington, Robert; Hunninghake, Donald; Pitt, Bertram; Furberg, Curt D. (2000-02-14)BACKGROUND: The efficacy of lipid-lowering therapy (LLT) has been well established for patients with preexisting coronary artery disease (CAD). However, limited information is available assessing the extent to which ...